Follicle Stimulating Hormone (FSH) Receptor Polymorphisms in In-Vitro Fertilization Cycles. - NCT01002885-07030 (Clinical Trial 385545)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy385545.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Hoboken |
|
State:
|
|
NJ |
| Zip Code: |
|
07030 |
| Conditions: |
|
Infertility |
| Purpose: |
|
This study is being done to identify if certain sequences (patterns) of key genes (called
polymorphisms) may predict a response to fertility medications. The investigators will also
determine if the individual response to fertility medications affects pregnancy rates in
in-vitro fertilization.
|
| Study summary: |
|
All IVF patients who meet inclusion criteria and not exclusion criteria will be asked to
participate in this study. Upon consent, a blood sample will be obtained in 2 EDTA
containing lavender topped tubes before, during or within 3 months after their IVF cycle.
Genomic DNA will be extracted and saved for genotyping.
The Investigators will collect data on each individual's age, ethnic background, and
estradiol levels on the day of hCG administration, total gonadotropin amount, clinical
pregnancy rates, basal FSH levels, and occurrence of OHSS. The Investigators will then
analyze all samples from all patients for their FSH receptor genotypes.
Patients will be compensated $75 via a check within 6-8 weeks of their blood drawn. |
| Criteria: |
|
Inclusion Criteria:
1. 100 women less than 35 years old at time of signing the Informed Consent Form.
2. Day 3 FSH level less than or equal to 10 mIU/ml with an estradiol < 70 pg/ml
3. Day 3 antral follicle count of greater than 10 follicles total.
4. Couples who have male factor infertility, tubal factor infertility, and unexplained
infertility.
Exclusion Criteria patients who have:
1. Endometriosis
2. Polycystic ovarian syndrome |
|
|
|
| Study is available at: |
|
University Reproductive Associates
Hoboken, NJ 07030
United States
Primary Contact:
Aimee Seungdamrong, MD
Email: aseung@uranj.com
Phone: 201-830-3450
Secondary Contact:
Amy Solnica, RN, MSN
Email: amysolnica@gmail.com
Phone: 973-972-3633 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 16, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|